Aviva PLC Enanta Pharmaceuticals Inc Transaction History

Aviva PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$43.76 - $53.11 $1.09 Million - $1.32 Million	-24,885 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$41.69 - $54.95 $141,412 - $186,390	-3,392 Reduced 12.0%	24,885 $1.23 Million
Q4 2020 Feb 10, 2021	SELL	$41.16 - $47.47 $943,551 - $1.09 Million	-22,924 Reduced 44.77%	28,277 $1.19 Million
Q3 2020 Nov 12, 2020	BUY	$43.36 - $53.53 $200,800 - $247,897	4,631 Added 9.94%	51,201 $2.34 Million
Q2 2020 Aug 13, 2020	SELL	$46.37 - $57.58 $1.32 Million - $1.64 Million	-28,464 Reduced 37.93%	46,570 $2.34 Million
Q1 2020 May 14, 2020	BUY	$40.22 - $62.0 $1.79 Million - $2.76 Million	44,451 Added 145.35%	75,034 $3.86 Million
Q4 2019 Feb 10, 2020	BUY	$57.95 - $66.61 $1.77 Million - $2.04 Million	30,583 New	30,583 $1.89 Million

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.